Coughs, Coiled Coils, and the Class­room Cliché of Con­for­ma­tional Change

by Daniel P. Haeusser

"Sally has the whoop­ing cough…"

Fig­ure 1 (A) Per­tus­sis: Whoop­ing Cough Vac­ci­nate to Pro­tect Poster from the Cen­ters for Dis­ease Con­trol and Pre­ven­tion. (Source) (B) An in­fant with per­tus­sis is given an oxy­gen mask. Photo credit: ©WGBH Edu­ca­tional Foun­da­tion. Source

So starts a verse in a mod­ern ver­sion of the children's folk song Pop Goes the Weasel. The 'whoop­ing' sound gen­er­ated through strug­gles for breath fol­low­ing fits of in­tense cough­ing char­ac­ter­izes per­tus­sis. Caused by the beta-pro­teobac­te­ria Bor­de­tella per­tus­sis, this highly con­ta­gious dis­ease can se­ri­ously af­flict hu­mans of any age, par­tic­u­larly ba­bies. En­demic in the United States, per­tus­sis peaks in cy­cles of three to five years, with the last peak out­break in 2012 with over 48,000 re­ported cases. (In fact, at the time, this was the dis­cussed in TWiM #38) World­wide es­ti­mates cal­cu­late that there have been ap­prox­i­mately 16 mil­lion re­ported per­tus­sis cases and be­tween 200,000 – 300,000 per­tus­sis-re­lated fa­tal­i­ties per year. Since 2000, with the ad­vent of a new, less po­tent acel­lu­lar per­tus­sis vac­cine and a dis­turb­ing rise in vac­cine re­fusal, over­all en­demic per­tus­sis rates have been on the rise, with ma­jor out­breaks be­com­ing more fre­quent (such as a 2010 out­break not long pre­ced­ing the 2012 peak).

With hu­mans (and other apes) as the only known reser­voir for B. per­tus­sis, the most ef­fec­tive pre­ven­ta­tive mea­sure against its dis­ease re­mains vac­ci­na­tion as part of the diph­the­ria, tetanus, and per­tus­sis (DTP) im­mu­niza­tion, and the pre­ven­tion of its spread through the hu­man pop­u­la­tion via air­borne droplets (Fig­ure 1A). How­ever, once an in­di­vid­ual be­comes in­fected with the bac­te­ria and af­ter dis­ease symp­toms set in, rapid treat­ment with an­tibi­otics is es­sen­tial, along with breath­ing aids (Fig­ure 1B). As with all pathogens, ma­jor goals of re­search are a greater un­der­stand­ing of the bi­o­log­i­cal ba­sis of their vir­u­lence and the elu­ci­da­tion of mech­a­nisms that could sug­gest tar­gets for novel an­timi­cro­bial com­pounds. So what mol­e­cules does B. per­tus­sis em­ploy to cause its dev­as­ta­tion, and how?

A num­ber of vir­u­lence fac­tors are re­spon­si­ble for B. per­tus­sis patho­gen­e­sis (re­viewed here). Within the up­per res­pi­ra­tory tract, the bac­te­ria at­tach to ep­ithe­lial cell cilia and se­crete a toxin that par­a­lyze the cilia, caus­ing in­flam­ma­tion and pre­vent­ing clear­ing of mu­cus and de­bris from the lungs. Mean­while, a sec­ond bac­te­r­ial se­creted toxin in­ter­feres with G pro­tein cou­pled sig­nal­ing, thereby block­ing nu­mer­ous com­po­nents of the in­nate im­mu­nity. As is com­mon for bac­te­ria, the change in en­vi­ron­ment for Bor­de­tella from out­side the host to up­per res­pi­ra­tory tract en­try is ac­com­pa­nied by a re­set of ge­netic ex­pres­sion from one ap­pro­pri­ate for the avir­u­lent state to one tai­lored for the vir­u­lent state. This story has been un­rav­eled in some de­tail us­ing the tools of mi­cro­bial ge­net­ics and struc­tural pro­tein bi­ol­ogy.

Bv­gAS : Mas­ter reg­u­la­tor of B. per­tus­sis patho­gen­e­sis

Fig­ure 2. The Bv­gAS two-com­po­nent reg­u­la­tory sys­tem. The mul­tido­main con­tain­ing BvgS is a his­ti­dine sen­sor ki­nase that ac­ti­vates upon re­ceipt of en­vi­ron­men­tal sig­nals to au­tophos­pho­ry­late (dimer not shown) and to ini­ti­ate a phos­pho­trans­fer re­lay. The phos­pho­ryl group ul­ti­mately trans­fers to BvgA, the re­sponse reg­u­la­tor. Phos­pho­ry­lated BvgA dimer­izes (not shown), at which point it both ac­ti­vates the ex­pres­sion of vir­u­lence-as­so­ci­ated genes (vag loci) and re­presses the ex­pres­sion of vir­u­lence-re­pressed genes (vrg loci). See text for dis­cus­sion of rel­e­vant do­mains (VFT = venus fly­trap, PAS = Per Arnt Sim, HK = his­ti­dine ki­nase, Rec = Re­ceiver, Hpt = his­ti­dine phos­pho­ryl trans­fer, and HTH = he­lix-turn-he­lix) (Source: Melvin et al. Nat. Rev. Mi­cro­biol.)

A two-com­po­nent phos­pho­re­lay sys­tem (TCS) named Bv­gAS is re­spon­si­ble for con­trol­ling this switch from avir­u­lent to vir­u­lent gene ex­pres­sion. Bv­gAS thus gov­erns ex­pres­sion of both tox­ins men­tioned above, as well as that of the many other fac­tors in­volved in B. per­tus­sis vir­u­lence. In this sys­tem, BvgS is the mul­tido­main, his­ti­dine-ki­nase re­cep­tor that can phos­pho­ry­late (ac­ti­vate) BvgA, the re­sponse reg­u­la­tor that serves as a tran­scrip­tional reg­u­la­tor of vir­u­lence genes (Fig­ure 2). Con­versely, BvgS can also act in re­verse, as a phos­phatase, and de­ac­ti­vate BvgA. While lig­ands and con­di­tions in the lab are known to de­ac­ti­vate sig­nal­ing, what ac­ti­vates sig­nal­ing within the in vivo path­o­genic con­di­tion re­mains un­clear. A re­cent mBio re­port by Lesne et al. char­ac­ter­izes the me­chan­i­cal reg­u­la­tion of BvgS ac­tiv­ity in terms of dy­namic changes to its over­all struc­ture through trig­gered shifts in its con­stituent do­mains, par­tic­u­larly via the sta­bil­ity of coiled-coil he­lices.

I found this re­port in­ter­est­ing on two lev­els. First, it show­cases the im­por­tance of bio­chem­istry – struc­tural mech­a­nism – to un­der­stand­ing bi­ol­ogy, at the level of patho­gen­e­sis and dis­ease. It is a run­ning joke in bio­chem­istry classes that the an­swer to so many ques­tions can be sim­pli­fied down to a cliché of "con­for­ma­tional change" and "sta­bil­ity of struc­tures". Pro­teins re­ceive sig­nal, and 'pop' goes the pro­tein, chang­ing shape to phys­i­cally carry out con­se­quences. And then again 'pop goes the pro­tein' re­set­ting it back to its ini­tial shape. How­ever, for par­tic­u­lar sys­tems, it is im­mensely im­por­tant to tease out the mol­e­c­u­lar de­tails of this gen­eral con­for­ma­tional change. This is par­tic­u­larly true for those sys­tems like a TCS whose op­er­a­tion is cen­tral to the vir­u­lence of a deadly pathogen. Which brings us to the sec­ond point of in­ter­est for this study: this par­tic­u­lar re­search is not only rel­e­vant to B. per­tus­sis, but also to other im­por­tant hu­man pathogens that con­tain Bv­gAS ho­mologs in­volved in vir­u­lence, in­clud­ing Vib­rio, Yersinia, and Bor­re­lia species.

The au­thors of the re­port fo­cused their study on BvgS, the sen­sor his­ti­dine ki­nase, to ad­dress the role of a 2‑helix coiled coil do­main within the linker re­gion be­tween two in­tra­cel­lu­lar do­mains of BvgS, the PAS and HK do­mains (Fig­ure 2). Be­fore fo­cus­ing on that how­ever, a brief overview of the mul­ti­ple do­mains of BvgS to put things in con­text.

Fig­ure 3. The PAS – HK linker of BvgS. (A) Car­toon of the BvgS dimer. (The Rec and HPt do­mains are not shown). The HK do­main is com­posed of a DHp re­gion where the phos­pho­ry­lat­able his­ti­dine residue lies and a CA re­gion that can bind ATP for catal­y­sis. (B) Amino acid se­quence of the PAS – HK coiled-coil linker show­ing the a and d residues of the three hep­tad re­peats. Be­low that is a he­li­cal wheel di­a­gram of the coiled-coil. Hy­dropho­bic residues are in grey, po­lar un­charged residues in or­ange, neg­a­tive residues in red, and pos­i­tive residues in blue. (Source)

First, BvgS con­tains a pair of periplas­mic do­mains whose fam­ily is named 'Venus fly­trap' (VFT), a name that de­rives from the ac­tiv­ity of clamp­ing onto lig­and. They are un­usual in canon­i­cal TCS, be­ing more com­mon in trans­port sys­tems. Con­for­ma­tional change in the VFT upon lig­and bind­ing trans­lates to struc­tural changes in the cy­to­plas­mic por­tion of BvgS, start­ing in a PAS do­main, which is typ­i­cally found in sig­nal­ing pro­teins. Con­for­ma­tional change prop­a­gates then to the his­ti­dine ki­nase (HK) do­main of BvgS, which it­self can be sub­di­vided into two dis­tinct re­gions: a DHp re­gion that con­tains the ac­tual phos­pho­ry­lat­able his­ti­dine residue, and the ATP-bind­ing cat­alytic re­gion (CA) it­self (Fig­ure 3A). The phos­pho­re­lay process then con­tin­ues through the BvgS re­ceiver (Rec) and his­ti­dine phos­pho­ryl trans­fer (Hpt) do­mains to ul­ti­mately ac­ti­vate BvgA.

Again, the au­thors fo­cused their re­search on a coiled-coil pre­dicted to form within the linker re­gion of BvgS be­tween its PAS and HK do­mains. The role and im­por­tance of this pre­dicted coiled-coil in Bv­gAS sig­nal­ing was un­known. How­ever, both their pre­vi­ous re­search on BvgS and stud­ies of sim­i­lar struc­tural fea­tures within un­re­lated TCSs (such as here) sug­gested to the au­thors im­por­tance for this coiled-coil.

BvgS: A bal­ance be­tween rigid­ity and flex­i­bil­ity

How does one go about test­ing the im­por­tance of a coiled-coil do­main for a protein's func­tion? Two-he­lix coiled-coils are de­fined by stretches of seven amino acid re­peats that form two he­li­cal turns. The first and fourth residues of this hep­tad re­peat are gen­er­ally hy­dropho­bic, al­low­ing in­ter­face be­tween the two he­lices, while the other residues are typ­i­cally po­lar, pro­mot­ing the he­lix for­ma­tion it­self (Fig­ure 3B). The au­thors' ex­per­i­ments pri­mar­ily in­volved al­ter­ing the length of this coiled-coil linker re­gion or chang­ing in­di­vid­ual amino acids be­tween leucine or ala­nine to shift the linker be­tween states of flex­i­bil­ity (mostly Ala) and rigid­ity (mostly Leu, to ef­fec­tively now be a sta­ble leucine zip­per). To as­say the ac­tiv­ity of these al­tered BvgS mu­tants, the au­thors used lacZ tran­scrip­tional fu­sion re­porters of b‑galactosidase ac­tiv­ity within B. per­tus­sis. Sig­nal from these re­porters would be trig­gered by BvgA if it, in turn, was ac­ti­vated through phos­pho­trans­fer from a given BvgS mu­tant. The au­thors ad­di­tion­ally used Cys-scan­ning analy­sis on a trun­cated BvgS ex­pressed in E. coli cells to ad­dress in­ter­dimer S‑S bond for­ma­tion within the linker re­gion, con­firm­ing coiled-coil for­ma­tion. This also al­lowed them to cor­re­late phe­no­types seen for ki­nase ac­tiv­ity of the coiled-coil mu­tants in the lacZ re­porter as­says with changes in coiled-coil struc­ture seen through dimer­iza­tion dy­nam­ics via Cys-scan­ning.

The au­thors found that the length of the coiled-coil linker be­tween the PAS and HK do­mains was ex­tremely im­por­tant, with the ad­di­tion of even one hep­tad com­pletely ab­ro­gat­ing the BvgS-me­di­ated sig­nal­ing, as did in­ser­tion of one or four residues to shift the reg­is­ter of the coiled-coil. Most im­por­tantly, shift­ing the coiled-coil sta­bil­ity be­tween rigid and flex­i­ble through re­place­ment of residues with leucine or ala­nine re­vealed at least some of the con­for­ma­tional change un­der­ly­ing the switch be­tween BvgS ac­tiv­ity as a ki­nase (vir­u­lent state) or phos­phatase (avir­u­lent state). A leucine-rich linker re­sem­bling a rigid leucine zip­per adopts a low-en­ergy con­for­ma­tion in­duced through a buried hy­dropho­bic in­ter­face be­tween he­lices, and this con­for­ma­tion for the coiled-coil pre­vents vir­u­lence gene ac­ti­va­tion (pre­sum­ably through act­ing as a phos­phatase on BvgA). In con­trast, a highly flex­i­ble con­for­ma­tion for the coiled-coil im­posed by ala­nine-rich se­quence fa­vored keep­ing BvgS in its ki­nase state, even in the pres­ence of lig­ands iden­ti­fied in the lab that nor­mally turn it off. The proper length and com­po­si­tion of this coiled-coil within BvgS be­tween its PAS and HK do­mains is there­fore es­sen­tial for struc­ture dy­nam­ics that al­low the sen­sor ki­nase to act prop­erly as a mas­ter reg­u­la­tory switch.

Unan­swered Ques­tions

Though the au­thors re­search clearly points to the im­por­tance for the dy­namic struc­ture of this coiled-coil linker in BvgS ac­tiv­ity, other ex­per­i­ments they per­formed in­di­cated that these dy­nam­ics are com­pletely in­de­pen­dent of the pres­ence of the PAS do­main. Pre­vi­ous re­search in­di­cates that the PAS do­main is im­por­tant for BvgS ac­tiv­ity in B. per­tus­sis, and may even have a role in sig­nal sens­ing. But how its con­for­ma­tion and re­sponse to lig­and bind­ing trans­lates into coiled-coil dy­nam­ics and sub­se­quent ac­tiv­ity as­so­ci­ated through phos­pho­trans­fer is un­known. Ad­di­tion­ally, not all BvgS fam­ily mem­bers con­tain the PAS do­main, mean­ing it may have a more spe­cial­ized role de­pend­ing on the species.

While this re­port in mBio does a good job of ad­dress­ing the bio­chem­istry of this coiled-coil do­main within BvgS, it lacks analy­sis of mu­tants dur­ing in vivo in­fec­tion. While B. per­tus­sis does not nor­mally in­fect an­i­mals out­side of pri­mates, ar­ti­fi­cial re­search mod­els do ex­ist, such as through mouse or pig in­fec­tion.

The pres­ence of BvgS ho­mologs with sim­i­lar coiled-coil re­gions in other pathogens sug­gests that dy­nam­ics of such a linker re­gion may be im­por­tant for mas­ter reg­u­la­tion of vir­u­lence ac­ti­va­tion in sev­eral dis­eases. Ad­di­tion­ally, this ap­pears more broadly rel­e­vant even be­yond pathogens, as a sim­i­lar mech­a­nism is seen in an un­re­lated TCS of Bacil­lus sub­tilis, DesK, which is a more canon­i­cal sen­sor his­ti­dine ki­nase in­volved in re­sponse to cold tem­per­a­tures. In­ter­est­ingly, dy­nam­ics in the coiled-coil of this par­tic­u­lar sen­sor may not just in­volve con­for­ma­tional changes in the pro­tein it­self, but also in its lipid en­vi­ron­ment through tem­per­a­ture flux. But that's a chron­i­cle of con­for­ma­tional change for an­other time. In the mean­while, we can rel­ish in the el­e­gance of mod­ern struc­tural and ge­netic stud­ies done in com­bi­na­tion.

 

Daniel is an As­sis­tant Pro­fes­sor in the Bi­ol­ogy De­part­ment of Can­i­sius Col­lege in Buf­falo, New York. He teaches courses in the fresh­man and sopho­more in­tro­duc­tory se­quence, Gen­eral Mi­cro­bi­ol­ogy, and an in­te­grated En­vi­ron­men­tal & Path­o­genic Mi­cro­bi­ol­ogy course. In his lab he fo­cuses on un­der­grad­u­ate re­search men­tor­ing through projects on bac­te­r­ial cell di­vi­sion and phage fac­tors that sub­vert the bac­te­r­ial cy­toskele­ton. In ad­di­tion to sci­ence, he en­joys read­ing, writ­ing, and film. He can be found on Twit­ter and his book re­views at Read­ing 1000 Lives or on Goodreads.

 

Other Posts

  • Of Terms in Bi­ol­ogy: Ex­tru­somes

    by Elio — Ex­tru­somes are nasty mem­brane-bound struc­tures re­leased by cil­i­ates and fla­gel­lates. They come in a num­ber of va­ri­eties, the best stud­ied be­ing the tri­chocysts of para­me­cia. These can be dis­charged by the thou­sands per cell in re­sponse to phys­i­cal stim­uli, in­clud­ing when at­tacked by preda­tors. In­stead of be­ing used...

  • Mi­cro­bial Em­braces

    by Elio — There are em­braces and there are em­braces. Some may last for a life­time, as was thought to be the case with some schis­to­somes (though it turns out that a few pairs do get a di­vorce). Other con­tacts, as with hu­mans, may be­come quite in­ti­mate and lead to the trans­fer of bi­o­log­i­cal…

  • How to grow shrubs

    by Christoph — Ex­actly eight years ago to­day, we in­tro­duced you to the 'Hedge­hogs In Your Gar­den'. No, we had not turned our backs on the Small Things and be­came gar­den­ers in­stead. Again to­day, it is not about gar­den­ing ac­tiv­i­ties, namely, 'How to grow shrubs'. Let me ex­plain...